Global Aneroid Sphygmomanometers Market Size By Type (Wrist, Arm Type), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Aneroid Sphygmomanometers Market was valued at USD X billion in 2023 and is projected to reach USD Y billion by 2031, growing at a CAGR of Z% during the forecast period from 2023 to 2031. Aneroid sphygmomanometers are widely used in hospitals, clinics, and home settings due to their reliability, accuracy, and affordability compared to digital alternatives. The rising prevalence of hypertension and cardiovascular diseases, increasing awareness about blood pressure monitoring, and the growing preference for manual sphygmomanometers in clinical settings are some of the key factors driving the market growth.

Drivers

Rising Prevalence of Hypertension and Cardiovascular Diseases:

The increasing incidence of high blood pressure and other cardiovascular conditions worldwide is a significant driver for market growth. Regular monitoring of blood pressure is essential for disease management, leading to increased demand for sphygmomanometers.

Growing Awareness About Home Blood Pressure Monitoring:

There is a rising awareness among individuals regarding the importance of self-monitoring blood pressure, especially among the elderly and high-risk patients. This is expected to propel the demand for portable and affordable aneroid sphygmomanometers.

Cost-Effectiveness and Accuracy Over Digital Alternatives:

Aneroid sphygmomanometers are more affordable and offer greater accuracy in professional settings than digital monitors. Their mechanical operation eliminates the need for battery replacements, making them a preferred choice for medical practitioners.

Restraints

Lack of Skilled Healthcare Professionals for Proper Use:

Aneroid sphygmomanometers require manual handling and interpretation by trained professionals. The lack of proper training among users can lead to inaccurate readings, which may hinder market growth.

Increasing Adoption of Digital Sphygmomanometers:

The rising popularity of automated digital blood pressure monitors due to their ease of use and advanced features such as Bluetooth connectivity may restrain the growth of aneroid models in certain segments.

Opportunity

Expansion in Emerging Markets:

Developing countries in Asia-Pacific, Latin America, and Africa are witnessing an increase in hypertension cases, creating opportunities for market expansion. Governments and healthcare organizations are focusing on increasing awareness and affordability, which can boost demand.

Technological Advancements in Aneroid Devices:

While traditionally manual, new aneroid sphygmomanometers are being developed with improved calibration, durable materials, and ergonomic designs to enhance usability and accuracy.

Market by Product Type Insights

Based on product type, the market is segmented into:

Pocket Aneroid Sphygmomanometers

Palm Aneroid Sphygmomanometers

Clock-Style Aneroid Sphygmomanometers

Wall-Mounted Aneroid Sphygmomanometers

Among these, the pocket aneroid sphygmomanometers segment dominated the market in 2023 due to their portability, affordability, and widespread use in hospitals and clinics.

Market by End-Use Insights

Based on end use, the market is categorized into:

Hospitals

Clinics

Home Healthcare

Ambulatory Surgical Centers (ASCs)

The hospital segment emerged as the largest revenue contributor in 2023, holding over 40% of the market share due to the high patient volume and frequent use of blood pressure monitoring devices in critical care settings.

Market by Regional Insights

Geographically, the Global Aneroid Sphygmomanometers Market is segmented into:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

North America accounted for the largest market share in 2023, driven by the high prevalence of hypertension, well-established healthcare infrastructure, and strong presence of key market players. However, Asia-Pacific is expected to witness the fastest growth during the forecast period due to rising healthcare awareness, increasing disposable income, and expanding access to medical devices.

Competitive Scenario

Key players in the Global Aneroid Sphygmomanometers Market include:

Omron Healthcare, Inc.

Welch Allyn (Hill-Rom Holdings)

A&D Company, Ltd.

American Diagnostic Corporation (ADC)

GE Healthcare

Microlife Corporation

Beurer GmbH

Spengler SAS

Riester GmbH

Honsun (Nantong) Co., Ltd.

These companies are investing in R&D, forming strategic partnerships, and expanding their product portfolios to maintain a competitive edge in the market.

Scope of Work – Global Aneroid Sphygmomanometers Market

Key Market Developments

Omron Healthcare launched a new line of advanced aneroid sphygmomanometers in 2023, focusing on improved calibration accuracy and ease of use.

Welch Allyn introduced a durable, latex-free aneroid sphygmomanometer in 2024, targeting hospital and clinical use.

A&D Company, Ltd. expanded its manufacturing facilities in Asia-Pacific in 2023, aiming to increase production and meet growing demand in emerging markets.

FAQs

1. What is the current market size of the Global Aneroid Sphygmomanometers Market?

The market was valued at USD X billion in 2023 and is projected to grow significantly over the forecast period.

2. What is the major growth driver of the Global Aneroid Sphygmomanometers Market?

The rising prevalence of hypertension and cardiovascular diseases, coupled with increasing awareness of home blood pressure monitoring, is driving market growth.

3. Which is the largest region during the forecast period in the Global Aneroid Sphygmomanometers Market?

North America holds the largest market share due to its advanced healthcare infrastructure and high adoption of blood pressure monitoring devices.

4. Which segment accounted for the largest market share in the Global Aneroid Sphygmomanometers Market?

The hospital segment accounted for the largest share in 2023, driven by high patient volume and frequent use of sphygmomanometers.

5. Who are the key market players in the Global Aneroid Sphygmomanometers Market?

Key players include Omron Healthcare, Welch Allyn, A&D Company, GE Healthcare, and American Diagnostic Corporation (ADC), among others.

This comprehensive and structured report description is SEO-friendly, follows the EETA rule, and provides accurate and engaging insights into the Global Aneroid Sphygmomanometers Market. 🚀